Phibro Animal Health Corporation logo

Phibro Animal Health Corporation (PAHC)

Market Closed
16 Oct, 08:00 PM
NASDAQ (NMS) NASDAQ (NMS)
$
38. 82
+0.84
+2.2117%
$
1.55B Market Cap
35.95 P/E Ratio
0.48% Div Yield
186,992 Volume
1.1 Eps
$ 37.98
Previous Close
Add Transaction
Day Range
37.52 38.94
Year Range
28.25 60.08
Want to track PAHC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Are You Looking for a Top Momentum Pick? Why Phibro Animal Health (PAHC) is a Great Choice

Are You Looking for a Top Momentum Pick? Why Phibro Animal Health (PAHC) is a Great Choice

Does Phibro Animal Health (PAHC) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks | 2 years ago
PAHC vs. ABT: Which Stock Should Value Investors Buy Now?

PAHC vs. ABT: Which Stock Should Value Investors Buy Now?

Investors interested in Medical - Products stocks are likely familiar with Phibro Animal Health (PAHC) and Abbott (ABT). But which of these two stocks offers value investors a better bang for their buck right now?

Zacks | 2 years ago
Here's Why Phibro Animal Health (PAHC) is a Strong Momentum Stock

Here's Why Phibro Animal Health (PAHC) is a Strong Momentum Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 2 years ago
Phibro (PAHC) International Revenue Performance Explored

Phibro (PAHC) International Revenue Performance Explored

Examine the evolution of Phibro's (PAHC) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.

Zacks | 2 years ago
Phibro Animal Health Corporation (PAHC) Q4 2024 Earnings Call Transcript

Phibro Animal Health Corporation (PAHC) Q4 2024 Earnings Call Transcript

Phibro Animal Health Corporation (NASDAQ:PAHC ) Q4 2024 Earnings Call Transcript August 29, 2024 9:00 AM ET Company Participants Glenn David - CFO Jack Bendheim - Chairman, President, and CEO Daniel Bendheim - Director and EVP of Corporate Strategy Conference Call Participants Michael Ryskin - Bank of America Navann Ty - BNP Paribas Operator Good morning. My name is Julianne and I will be your conference operator today.

Seekingalpha | 2 years ago
Here's Why Phibro Animal Health (PAHC) is a Strong Value Stock

Here's Why Phibro Animal Health (PAHC) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 2 years ago
Phibro Q4 Earnings and Revenues Beat, Operating Margin Down

Phibro Q4 Earnings and Revenues Beat, Operating Margin Down

PAHC's impressive fourth-quarter fiscal 2024 results can be attributed to the Animal Health segment's robust performance.

Zacks | 2 years ago
Here's What Key Metrics Tell Us About Phibro (PAHC) Q4 Earnings

Here's What Key Metrics Tell Us About Phibro (PAHC) Q4 Earnings

While the top- and bottom-line numbers for Phibro (PAHC) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks | 2 years ago
Phibro Animal Health (PAHC) Beats Q4 Earnings and Revenue Estimates

Phibro Animal Health (PAHC) Beats Q4 Earnings and Revenue Estimates

Phibro Animal Health (PAHC) came out with quarterly earnings of $0.41 per share, beating the Zacks Consensus Estimate of $0.34 per share. This compares to earnings of $0.38 per share a year ago.

Zacks | 2 years ago
Phibro (PAHC) Stock Jumps 10.2%: Will It Continue to Soar?

Phibro (PAHC) Stock Jumps 10.2%: Will It Continue to Soar?

Phibro (PAHC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Zacks | 2 years ago
Should Value Investors Buy Phibro Animal Health (PAHC) Stock?

Should Value Investors Buy Phibro Animal Health (PAHC) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks | 2 years ago
Countdown to Phibro (PAHC) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS

Countdown to Phibro (PAHC) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS

Besides Wall Street's top -and-bottom-line estimates for Phibro (PAHC), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2024.

Zacks | 2 years ago
Loading...
Load More